Furthermore, studies in mice carrying WT BBS MCF7 tumors revealed that shikonin treatment led to significantly reduced tumor growth, emphasizing the crucial role of targeting PKM2 signaling to inhibit the progression of tumors (36). This evidence concerns the gene PKM and neoplasm.